“In a recent trip to Russia, we prepared the ground for the export of $30 million of bio-based medicine, which is a remarkable figure,” Sattari told reporters in Tehran on Saturday.
The Iranian vice president had in late October paid a 3-day visit to Russia during which he met with high-ranking Russian officials and visited a number of science and research institutes and top universities of the country.
Elsewhere in his comments, Sattari expected that the value of export of pharmaceutical products to Russia would reach $300 million in the future.
Iran and Russia, both slapped by the West’s unilateral sanctions, have ramped up efforts to cooperate for getting around the sanctions.
Back in May, Iranian Health Minister Seyed Hassan Qazizadeh Hashemi and his Russian counterpart Veronika Skvortsova held a meeting to discuss the export of Iranian-made medicine and medical equipment to Russia.
At the meeting, held on the sidelines of the 67th World Health Assembly in Geneva, the two sides had exchanged views on expanding cooperation in the production of a medicine used for treating multiple sclerosis (MS).